Global Gene-based Advanced Therapy Medicinal Market 2022 by Company, Regions, Type and Application, Forecast to 2028
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The Gene-based Advanced Therapy Medicinal market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Gene-based Advanced Therapy Medicinal market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The Gene-based Advanced Therapy Medicinal market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Neurological Diseases occupied for % of the Gene-based Advanced Therapy Medicinal global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Viral Gene Delivery System segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Gene-based Advanced Therapy Medicinal include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics and Alnylam Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global Gene-based Advanced Therapy Medicinal market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.
Main Gene-based Advanced Therapy Medicinal companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global Gene-based Advanced Therapy Medicinal market based on the following parameters – headquarters, products portfolio, Gene-based Advanced Therapy Medicinal revenue and gross margin, recent developments.
Evaluation and forecast the Gene-based Advanced Therapy Medicinal market size, projected growth trends, and corresponding market share analysis by type, by application and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Gene-based Advanced Therapy Medicinal market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
Chapter 1, to describe Gene-based Advanced Therapy Medicinal product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Gene-based Advanced Therapy Medicinal, with revenue, gross margin and global market share of Gene-based Advanced Therapy Medicinal from 2019 to 2022.
Chapter 3, the Gene-based Advanced Therapy Medicinal competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Gene-based Advanced Therapy Medicinal market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Gene-based Advanced Therapy Medicinal research findings and conclusion, appendix and data source.
The Gene-based Advanced Therapy Medicinal market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Gene-based Advanced Therapy Medicinal market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The Gene-based Advanced Therapy Medicinal market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Neurological Diseases occupied for % of the Gene-based Advanced Therapy Medicinal global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Viral Gene Delivery System segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Gene-based Advanced Therapy Medicinal include Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics and Alnylam Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global Gene-based Advanced Therapy Medicinal market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.
Main Gene-based Advanced Therapy Medicinal companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global Gene-based Advanced Therapy Medicinal market based on the following parameters – headquarters, products portfolio, Gene-based Advanced Therapy Medicinal revenue and gross margin, recent developments.
Evaluation and forecast the Gene-based Advanced Therapy Medicinal market size, projected growth trends, and corresponding market share analysis by type, by application and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Gene-based Advanced Therapy Medicinal market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
- Viral Gene Delivery System
- Non-viral Gene Delivery System
- Neurological Diseases
- Cancer
- Other
- Biogen
- Novartis
- Gilead Sciences
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Amgen
- Spark Therapeutics
- Akcea Therapeutics
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
- Human Stem Cells Institute
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Australia)
- South America (Brazil, Argentina, Colombia and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa and Rest of Middle East & Africa)
Chapter 1, to describe Gene-based Advanced Therapy Medicinal product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Gene-based Advanced Therapy Medicinal, with revenue, gross margin and global market share of Gene-based Advanced Therapy Medicinal from 2019 to 2022.
Chapter 3, the Gene-based Advanced Therapy Medicinal competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Gene-based Advanced Therapy Medicinal market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Gene-based Advanced Therapy Medicinal research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Gene-based Advanced Therapy Medicinal
1.2 Classification of Gene-based Advanced Therapy Medicinal by Type
1.2.1 Overview: Global Gene-based Advanced Therapy Medicinal Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Type in 2021
1.2.3 Viral Gene Delivery System
1.2.4 Non-viral Gene Delivery System
1.3 Global Gene-based Advanced Therapy Medicinal Market by Application
1.3.1 Overview: Global Gene-based Advanced Therapy Medicinal Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Global Gene-based Advanced Therapy Medicinal Market Size & Forecast
1.5 Global Gene-based Advanced Therapy Medicinal Market Size and Forecast by Region
1.5.1 Global Gene-based Advanced Therapy Medicinal Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Gene-based Advanced Therapy Medicinal Market Size by Region, (2017-2022)
1.5.3 North America Gene-based Advanced Therapy Medicinal Market Size and Prospect (2017-2028)
1.5.4 Europe Gene-based Advanced Therapy Medicinal Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Gene-based Advanced Therapy Medicinal Market Size and Prospect (2017-2028)
1.5.6 South America Gene-based Advanced Therapy Medicinal Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Gene-based Advanced Therapy Medicinal Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gene-based Advanced Therapy Medicinal Market Drivers
1.6.2 Gene-based Advanced Therapy Medicinal Market Restraints
1.6.3 Gene-based Advanced Therapy Medicinal Trends Analysis
2 COMPANY PROFILES
2.1 Biogen
2.1.1 Biogen Details
2.1.2 Biogen Major Business
2.1.3 Biogen Gene-based Advanced Therapy Medicinal Product and Solutions
2.1.4 Biogen Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Biogen Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Gene-based Advanced Therapy Medicinal Product and Solutions
2.2.4 Novartis Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Gilead Sciences
2.3.1 Gilead Sciences Details
2.3.2 Gilead Sciences Major Business
2.3.3 Gilead Sciences Gene-based Advanced Therapy Medicinal Product and Solutions
2.3.4 Gilead Sciences Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Gilead Sciences Recent Developments and Future Plans
2.4 Sarepta Therapeutics
2.4.1 Sarepta Therapeutics Details
2.4.2 Sarepta Therapeutics Major Business
2.4.3 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Product and Solutions
2.4.4 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Sarepta Therapeutics Recent Developments and Future Plans
2.5 Alnylam Pharmaceuticals
2.5.1 Alnylam Pharmaceuticals Details
2.5.2 Alnylam Pharmaceuticals Major Business
2.5.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Product and Solutions
2.5.4 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Gene-based Advanced Therapy Medicinal Product and Solutions
2.6.4 Amgen Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Amgen Recent Developments and Future Plans
2.7 Spark Therapeutics
2.7.1 Spark Therapeutics Details
2.7.2 Spark Therapeutics Major Business
2.7.3 Spark Therapeutics Gene-based Advanced Therapy Medicinal Product and Solutions
2.7.4 Spark Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Spark Therapeutics Recent Developments and Future Plans
2.8 Akcea Therapeutics
2.8.1 Akcea Therapeutics Details
2.8.2 Akcea Therapeutics Major Business
2.8.3 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Product and Solutions
2.8.4 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Akcea Therapeutics Recent Developments and Future Plans
2.9 Sunway Biotech
2.9.1 Sunway Biotech Details
2.9.2 Sunway Biotech Major Business
2.9.3 Sunway Biotech Gene-based Advanced Therapy Medicinal Product and Solutions
2.9.4 Sunway Biotech Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Sunway Biotech Recent Developments and Future Plans
2.10 SIBIONO
2.10.1 SIBIONO Details
2.10.2 SIBIONO Major Business
2.10.3 SIBIONO Gene-based Advanced Therapy Medicinal Product and Solutions
2.10.4 SIBIONO Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 SIBIONO Recent Developments and Future Plans
2.11 AnGes
2.11.1 AnGes Details
2.11.2 AnGes Major Business
2.11.3 AnGes Gene-based Advanced Therapy Medicinal Product and Solutions
2.11.4 AnGes Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 AnGes Recent Developments and Future Plans
2.12 Orchard Therapeutics
2.12.1 Orchard Therapeutics Details
2.12.2 Orchard Therapeutics Major Business
2.12.3 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Product and Solutions
2.12.4 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Orchard Therapeutics Recent Developments and Future Plans
2.13 Human Stem Cells Institute
2.13.1 Human Stem Cells Institute Details
2.13.2 Human Stem Cells Institute Major Business
2.13.3 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Product and Solutions
2.13.4 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Human Stem Cells Institute Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Gene-based Advanced Therapy Medicinal Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Gene-based Advanced Therapy Medicinal Players Market Share in 2021
3.2.2 Top 10 Gene-based Advanced Therapy Medicinal Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Gene-based Advanced Therapy Medicinal Players Head Office, Products and Services Provided
3.4 Gene-based Advanced Therapy Medicinal Mergers & Acquisitions
3.5 Gene-based Advanced Therapy Medicinal New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Gene-based Advanced Therapy Medicinal Revenue and Market Share by Type (2017-2022)
4.2 Global Gene-based Advanced Therapy Medicinal Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Application (2017-2022)
5.2 Global Gene-based Advanced Therapy Medicinal Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2028)
6.2 North America Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2028)
6.3 North America Gene-based Advanced Therapy Medicinal Market Size by Country
6.3.1 North America Gene-based Advanced Therapy Medicinal Revenue by Country (2017-2028)
6.3.2 United States Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
6.3.3 Canada Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
6.3.4 Mexico Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2028)
7.2 Europe Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2028)
7.3 Europe Gene-based Advanced Therapy Medicinal Market Size by Country
7.3.1 Europe Gene-based Advanced Therapy Medicinal Revenue by Country (2017-2028)
7.3.2 Germany Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
7.3.3 France Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
7.3.5 Russia Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
7.3.6 Italy Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2028)
8.2 Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2028)
8.3 Asia-Pacific Gene-based Advanced Therapy Medicinal Market Size by Region
8.3.1 Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue by Region (2017-2028)
8.3.2 China Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
8.3.3 Japan Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
8.3.4 South Korea Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
8.3.5 India Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
8.3.7 Australia Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2028)
9.2 South America Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2028)
9.3 South America Gene-based Advanced Therapy Medicinal Market Size by Country
9.3.1 South America Gene-based Advanced Therapy Medicinal Revenue by Country (2017-2028)
9.3.2 Brazil Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
9.3.3 Argentina Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2028)
10.2 Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2028)
10.3 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Country
10.3.1 Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue by Country (2017-2028)
10.3.2 Turkey Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
10.3.4 UAE Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Gene-based Advanced Therapy Medicinal
1.2 Classification of Gene-based Advanced Therapy Medicinal by Type
1.2.1 Overview: Global Gene-based Advanced Therapy Medicinal Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Type in 2021
1.2.3 Viral Gene Delivery System
1.2.4 Non-viral Gene Delivery System
1.3 Global Gene-based Advanced Therapy Medicinal Market by Application
1.3.1 Overview: Global Gene-based Advanced Therapy Medicinal Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Global Gene-based Advanced Therapy Medicinal Market Size & Forecast
1.5 Global Gene-based Advanced Therapy Medicinal Market Size and Forecast by Region
1.5.1 Global Gene-based Advanced Therapy Medicinal Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Gene-based Advanced Therapy Medicinal Market Size by Region, (2017-2022)
1.5.3 North America Gene-based Advanced Therapy Medicinal Market Size and Prospect (2017-2028)
1.5.4 Europe Gene-based Advanced Therapy Medicinal Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Gene-based Advanced Therapy Medicinal Market Size and Prospect (2017-2028)
1.5.6 South America Gene-based Advanced Therapy Medicinal Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Gene-based Advanced Therapy Medicinal Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gene-based Advanced Therapy Medicinal Market Drivers
1.6.2 Gene-based Advanced Therapy Medicinal Market Restraints
1.6.3 Gene-based Advanced Therapy Medicinal Trends Analysis
2 COMPANY PROFILES
2.1 Biogen
2.1.1 Biogen Details
2.1.2 Biogen Major Business
2.1.3 Biogen Gene-based Advanced Therapy Medicinal Product and Solutions
2.1.4 Biogen Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Biogen Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Gene-based Advanced Therapy Medicinal Product and Solutions
2.2.4 Novartis Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Gilead Sciences
2.3.1 Gilead Sciences Details
2.3.2 Gilead Sciences Major Business
2.3.3 Gilead Sciences Gene-based Advanced Therapy Medicinal Product and Solutions
2.3.4 Gilead Sciences Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Gilead Sciences Recent Developments and Future Plans
2.4 Sarepta Therapeutics
2.4.1 Sarepta Therapeutics Details
2.4.2 Sarepta Therapeutics Major Business
2.4.3 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Product and Solutions
2.4.4 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Sarepta Therapeutics Recent Developments and Future Plans
2.5 Alnylam Pharmaceuticals
2.5.1 Alnylam Pharmaceuticals Details
2.5.2 Alnylam Pharmaceuticals Major Business
2.5.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Product and Solutions
2.5.4 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business
2.6.3 Amgen Gene-based Advanced Therapy Medicinal Product and Solutions
2.6.4 Amgen Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Amgen Recent Developments and Future Plans
2.7 Spark Therapeutics
2.7.1 Spark Therapeutics Details
2.7.2 Spark Therapeutics Major Business
2.7.3 Spark Therapeutics Gene-based Advanced Therapy Medicinal Product and Solutions
2.7.4 Spark Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Spark Therapeutics Recent Developments and Future Plans
2.8 Akcea Therapeutics
2.8.1 Akcea Therapeutics Details
2.8.2 Akcea Therapeutics Major Business
2.8.3 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Product and Solutions
2.8.4 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Akcea Therapeutics Recent Developments and Future Plans
2.9 Sunway Biotech
2.9.1 Sunway Biotech Details
2.9.2 Sunway Biotech Major Business
2.9.3 Sunway Biotech Gene-based Advanced Therapy Medicinal Product and Solutions
2.9.4 Sunway Biotech Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Sunway Biotech Recent Developments and Future Plans
2.10 SIBIONO
2.10.1 SIBIONO Details
2.10.2 SIBIONO Major Business
2.10.3 SIBIONO Gene-based Advanced Therapy Medicinal Product and Solutions
2.10.4 SIBIONO Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 SIBIONO Recent Developments and Future Plans
2.11 AnGes
2.11.1 AnGes Details
2.11.2 AnGes Major Business
2.11.3 AnGes Gene-based Advanced Therapy Medicinal Product and Solutions
2.11.4 AnGes Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 AnGes Recent Developments and Future Plans
2.12 Orchard Therapeutics
2.12.1 Orchard Therapeutics Details
2.12.2 Orchard Therapeutics Major Business
2.12.3 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Product and Solutions
2.12.4 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Orchard Therapeutics Recent Developments and Future Plans
2.13 Human Stem Cells Institute
2.13.1 Human Stem Cells Institute Details
2.13.2 Human Stem Cells Institute Major Business
2.13.3 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Product and Solutions
2.13.4 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Human Stem Cells Institute Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Gene-based Advanced Therapy Medicinal Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Gene-based Advanced Therapy Medicinal Players Market Share in 2021
3.2.2 Top 10 Gene-based Advanced Therapy Medicinal Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Gene-based Advanced Therapy Medicinal Players Head Office, Products and Services Provided
3.4 Gene-based Advanced Therapy Medicinal Mergers & Acquisitions
3.5 Gene-based Advanced Therapy Medicinal New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Gene-based Advanced Therapy Medicinal Revenue and Market Share by Type (2017-2022)
4.2 Global Gene-based Advanced Therapy Medicinal Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Application (2017-2022)
5.2 Global Gene-based Advanced Therapy Medicinal Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2028)
6.2 North America Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2028)
6.3 North America Gene-based Advanced Therapy Medicinal Market Size by Country
6.3.1 North America Gene-based Advanced Therapy Medicinal Revenue by Country (2017-2028)
6.3.2 United States Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
6.3.3 Canada Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
6.3.4 Mexico Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2028)
7.2 Europe Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2028)
7.3 Europe Gene-based Advanced Therapy Medicinal Market Size by Country
7.3.1 Europe Gene-based Advanced Therapy Medicinal Revenue by Country (2017-2028)
7.3.2 Germany Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
7.3.3 France Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
7.3.5 Russia Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
7.3.6 Italy Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2028)
8.2 Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2028)
8.3 Asia-Pacific Gene-based Advanced Therapy Medicinal Market Size by Region
8.3.1 Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue by Region (2017-2028)
8.3.2 China Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
8.3.3 Japan Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
8.3.4 South Korea Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
8.3.5 India Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
8.3.7 Australia Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2028)
9.2 South America Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2028)
9.3 South America Gene-based Advanced Therapy Medicinal Market Size by Country
9.3.1 South America Gene-based Advanced Therapy Medicinal Revenue by Country (2017-2028)
9.3.2 Brazil Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
9.3.3 Argentina Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2028)
10.2 Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2028)
10.3 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Country
10.3.1 Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue by Country (2017-2028)
10.3.2 Turkey Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
10.3.4 UAE Gene-based Advanced Therapy Medicinal Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global Gene-based Advanced Therapy Medicinal Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Gene-based Advanced Therapy Medicinal Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Gene-based Advanced Therapy Medicinal Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Gene-based Advanced Therapy Medicinal Revenue (USD Million) by Region (2017-2022)
Table 5. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Region (2023-2028)
Table 6. Biogen Corporate Information, Head Office, and Major Competitors
Table 7. Biogen Major Business
Table 8. Biogen Gene-based Advanced Therapy Medicinal Product and Solutions
Table 9. Biogen Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Gene-based Advanced Therapy Medicinal Product and Solutions
Table 13. Novartis Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 15. Gilead Sciences Major Business
Table 16. Gilead Sciences Gene-based Advanced Therapy Medicinal Product and Solutions
Table 17. Gilead Sciences Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Sarepta Therapeutics Corporate Information, Head Office, and Major Competitors
Table 19. Sarepta Therapeutics Major Business
Table 20. Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Product and Solutions
Table 21. Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Alnylam Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Alnylam Pharmaceuticals Major Business
Table 24. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Product and Solutions
Table 25. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Amgen Corporate Information, Head Office, and Major Competitors
Table 27. Amgen Major Business
Table 28. Amgen Gene-based Advanced Therapy Medicinal Product and Solutions
Table 29. Amgen Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Spark Therapeutics Corporate Information, Head Office, and Major Competitors
Table 31. Spark Therapeutics Major Business
Table 32. Spark Therapeutics Gene-based Advanced Therapy Medicinal Product and Solutions
Table 33. Spark Therapeutics Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Akcea Therapeutics Corporate Information, Head Office, and Major Competitors
Table 35. Akcea Therapeutics Major Business
Table 36. Akcea Therapeutics Gene-based Advanced Therapy Medicinal Product and Solutions
Table 37. Akcea Therapeutics Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Sunway Biotech Corporate Information, Head Office, and Major Competitors
Table 39. Sunway Biotech Major Business
Table 40. Sunway Biotech Gene-based Advanced Therapy Medicinal Product and Solutions
Table 41. Sunway Biotech Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. SIBIONO Corporate Information, Head Office, and Major Competitors
Table 43. SIBIONO Major Business
Table 44. SIBIONO Gene-based Advanced Therapy Medicinal Product and Solutions
Table 45. SIBIONO Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. AnGes Corporate Information, Head Office, and Major Competitors
Table 47. AnGes Major Business
Table 48. AnGes Gene-based Advanced Therapy Medicinal Product and Solutions
Table 49. AnGes Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Orchard Therapeutics Corporate Information, Head Office, and Major Competitors
Table 51. Orchard Therapeutics Major Business
Table 52. Orchard Therapeutics Gene-based Advanced Therapy Medicinal Product and Solutions
Table 53. Orchard Therapeutics Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Human Stem Cells Institute Corporate Information, Head Office, and Major Competitors
Table 55. Human Stem Cells Institute Major Business
Table 56. Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Product and Solutions
Table 57. Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Gene-based Advanced Therapy Medicinal Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Gene-based Advanced Therapy Medicinal Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Gene-based Advanced Therapy Medicinal by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Gene-based Advanced Therapy Medicinal Players Head Office, Products and Services Provided
Table 62. Gene-based Advanced Therapy Medicinal Mergers & Acquisitions in the Past Five Years
Table 63. Gene-based Advanced Therapy Medicinal New Entrants and Expansion Plans
Table 64. Global Gene-based Advanced Therapy Medicinal Revenue (USD Million) by Type (2017-2022)
Table 65. Global Gene-based Advanced Therapy Medicinal Revenue Share by Type (2017-2022)
Table 66. Global Gene-based Advanced Therapy Medicinal Revenue Forecast by Type (2023-2028)
Table 67. Global Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2022)
Table 68. Global Gene-based Advanced Therapy Medicinal Revenue Forecast by Application (2023-2028)
Table 69. North America Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Gene-based Advanced Therapy Medicinal Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Gene-based Advanced Therapy Medicinal Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Gene-based Advanced Therapy Medicinal Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Gene-based Advanced Therapy Medicinal Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Gene-based Advanced Therapy Medicinal Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Gene-based Advanced Therapy Medicinal Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Gene-based Advanced Therapy Medicinal Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Gene-based Advanced Therapy Medicinal Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Gene-based Advanced Therapy Medicinal Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Gene-based Advanced Therapy Medicinal Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Gene-based Advanced Therapy Medicinal Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Gene-based Advanced Therapy Medicinal Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue by Country (2023-2028) & (USD Million)
Table 1. Global Gene-based Advanced Therapy Medicinal Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Gene-based Advanced Therapy Medicinal Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Gene-based Advanced Therapy Medicinal Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Gene-based Advanced Therapy Medicinal Revenue (USD Million) by Region (2017-2022)
Table 5. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Region (2023-2028)
Table 6. Biogen Corporate Information, Head Office, and Major Competitors
Table 7. Biogen Major Business
Table 8. Biogen Gene-based Advanced Therapy Medicinal Product and Solutions
Table 9. Biogen Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Gene-based Advanced Therapy Medicinal Product and Solutions
Table 13. Novartis Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 15. Gilead Sciences Major Business
Table 16. Gilead Sciences Gene-based Advanced Therapy Medicinal Product and Solutions
Table 17. Gilead Sciences Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Sarepta Therapeutics Corporate Information, Head Office, and Major Competitors
Table 19. Sarepta Therapeutics Major Business
Table 20. Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Product and Solutions
Table 21. Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Alnylam Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Alnylam Pharmaceuticals Major Business
Table 24. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Product and Solutions
Table 25. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Amgen Corporate Information, Head Office, and Major Competitors
Table 27. Amgen Major Business
Table 28. Amgen Gene-based Advanced Therapy Medicinal Product and Solutions
Table 29. Amgen Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Spark Therapeutics Corporate Information, Head Office, and Major Competitors
Table 31. Spark Therapeutics Major Business
Table 32. Spark Therapeutics Gene-based Advanced Therapy Medicinal Product and Solutions
Table 33. Spark Therapeutics Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Akcea Therapeutics Corporate Information, Head Office, and Major Competitors
Table 35. Akcea Therapeutics Major Business
Table 36. Akcea Therapeutics Gene-based Advanced Therapy Medicinal Product and Solutions
Table 37. Akcea Therapeutics Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Sunway Biotech Corporate Information, Head Office, and Major Competitors
Table 39. Sunway Biotech Major Business
Table 40. Sunway Biotech Gene-based Advanced Therapy Medicinal Product and Solutions
Table 41. Sunway Biotech Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. SIBIONO Corporate Information, Head Office, and Major Competitors
Table 43. SIBIONO Major Business
Table 44. SIBIONO Gene-based Advanced Therapy Medicinal Product and Solutions
Table 45. SIBIONO Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. AnGes Corporate Information, Head Office, and Major Competitors
Table 47. AnGes Major Business
Table 48. AnGes Gene-based Advanced Therapy Medicinal Product and Solutions
Table 49. AnGes Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Orchard Therapeutics Corporate Information, Head Office, and Major Competitors
Table 51. Orchard Therapeutics Major Business
Table 52. Orchard Therapeutics Gene-based Advanced Therapy Medicinal Product and Solutions
Table 53. Orchard Therapeutics Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Human Stem Cells Institute Corporate Information, Head Office, and Major Competitors
Table 55. Human Stem Cells Institute Major Business
Table 56. Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Product and Solutions
Table 57. Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Gene-based Advanced Therapy Medicinal Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Gene-based Advanced Therapy Medicinal Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Gene-based Advanced Therapy Medicinal by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Gene-based Advanced Therapy Medicinal Players Head Office, Products and Services Provided
Table 62. Gene-based Advanced Therapy Medicinal Mergers & Acquisitions in the Past Five Years
Table 63. Gene-based Advanced Therapy Medicinal New Entrants and Expansion Plans
Table 64. Global Gene-based Advanced Therapy Medicinal Revenue (USD Million) by Type (2017-2022)
Table 65. Global Gene-based Advanced Therapy Medicinal Revenue Share by Type (2017-2022)
Table 66. Global Gene-based Advanced Therapy Medicinal Revenue Forecast by Type (2023-2028)
Table 67. Global Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2022)
Table 68. Global Gene-based Advanced Therapy Medicinal Revenue Forecast by Application (2023-2028)
Table 69. North America Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Gene-based Advanced Therapy Medicinal Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Gene-based Advanced Therapy Medicinal Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Gene-based Advanced Therapy Medicinal Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Gene-based Advanced Therapy Medicinal Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Gene-based Advanced Therapy Medicinal Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Gene-based Advanced Therapy Medicinal Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Gene-based Advanced Therapy Medicinal Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Gene-based Advanced Therapy Medicinal Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Gene-based Advanced Therapy Medicinal Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Gene-based Advanced Therapy Medicinal Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Gene-based Advanced Therapy Medicinal Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Gene-based Advanced Therapy Medicinal Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Gene-based Advanced Therapy Medicinal Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. Gene-based Advanced Therapy Medicinal Picture
Figure 2. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Type in 2021
Figure 3. Viral Gene Delivery System
Figure 4. Non-viral Gene Delivery System
Figure 5. Gene-based Advanced Therapy Medicinal Revenue Market Share by Application in 2021
Figure 6. Neurological Diseases Picture
Figure 7. Cancer Picture
Figure 8. Other Picture
Figure 9. Global Gene-based Advanced Therapy Medicinal Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Gene-based Advanced Therapy Medicinal Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Region (2017-2028)
Figure 12. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Region in 2021
Figure 13. North America Gene-based Advanced Therapy Medicinal Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Gene-based Advanced Therapy Medicinal Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Gene-based Advanced Therapy Medicinal Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Gene-based Advanced Therapy Medicinal Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Gene-based Advanced Therapy Medicinal Market Drivers
Figure 19. Gene-based Advanced Therapy Medicinal Market Restraints
Figure 20. Gene-based Advanced Therapy Medicinal Market Trends
Figure 21. Biogen Recent Developments and Future Plans
Figure 22. Novartis Recent Developments and Future Plans
Figure 23. Gilead Sciences Recent Developments and Future Plans
Figure 24. Sarepta Therapeutics Recent Developments and Future Plans
Figure 25. Alnylam Pharmaceuticals Recent Developments and Future Plans
Figure 26. Amgen Recent Developments and Future Plans
Figure 27. Spark Therapeutics Recent Developments and Future Plans
Figure 28. Akcea Therapeutics Recent Developments and Future Plans
Figure 29. Sunway Biotech Recent Developments and Future Plans
Figure 30. SIBIONO Recent Developments and Future Plans
Figure 31. AnGes Recent Developments and Future Plans
Figure 32. Orchard Therapeutics Recent Developments and Future Plans
Figure 33. Human Stem Cells Institute Recent Developments and Future Plans
Figure 34. Global Gene-based Advanced Therapy Medicinal Revenue Share by Players in 2021
Figure 35. Gene-based Advanced Therapy Medicinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 36. Global Top 3 Players Gene-based Advanced Therapy Medicinal Revenue Market Share in 2021
Figure 37. Global Top 10 Players Gene-based Advanced Therapy Medicinal Revenue Market Share in 2021
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 39. Global Gene-based Advanced Therapy Medicinal Revenue Share by Type in 2021
Figure 40. Global Gene-based Advanced Therapy Medicinal Market Share Forecast by Type (2023-2028)
Figure 41. Global Gene-based Advanced Therapy Medicinal Revenue Share by Application in 2021
Figure 42. Global Gene-based Advanced Therapy Medicinal Market Share Forecast by Application (2023-2028)
Figure 43. North America Gene-based Advanced Therapy Medicinal Sales Market Share by Type (2017-2028)
Figure 44. North America Gene-based Advanced Therapy Medicinal Sales Market Share by Application (2017-2028)
Figure 45. North America Gene-based Advanced Therapy Medicinal Revenue Market Share by Country (2017-2028)
Figure 46. United States Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Gene-based Advanced Therapy Medicinal Sales Market Share by Type (2017-2028)
Figure 50. Europe Gene-based Advanced Therapy Medicinal Sales Market Share by Application (2017-2028)
Figure 51. Europe Gene-based Advanced Therapy Medicinal Revenue Market Share by Country (2017-2028)
Figure 52. Germany Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Gene-based Advanced Therapy Medicinal Sales Market Share by Type (2017-2028)
Figure 58. Asia-Pacific Gene-based Advanced Therapy Medicinal Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue Market Share by Region (2017-2028)
Figure 60. China Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South Korea Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Gene-based Advanced Therapy Medicinal Sales Market Share by Type (2017-2028)
Figure 67. South America Gene-based Advanced Therapy Medicinal Sales Market Share by Application (2017-2028)
Figure 68. South America Gene-based Advanced Therapy Medicinal Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East and Africa Gene-based Advanced Therapy Medicinal Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Gene-based Advanced Therapy Medicinal Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Gene-based Advanced Therapy Medicinal Revenue Market Share by Country (2017-2028)
Figure 74. Turkey Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. UAE Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
Figure 1. Gene-based Advanced Therapy Medicinal Picture
Figure 2. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Type in 2021
Figure 3. Viral Gene Delivery System
Figure 4. Non-viral Gene Delivery System
Figure 5. Gene-based Advanced Therapy Medicinal Revenue Market Share by Application in 2021
Figure 6. Neurological Diseases Picture
Figure 7. Cancer Picture
Figure 8. Other Picture
Figure 9. Global Gene-based Advanced Therapy Medicinal Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Gene-based Advanced Therapy Medicinal Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Region (2017-2028)
Figure 12. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Region in 2021
Figure 13. North America Gene-based Advanced Therapy Medicinal Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Gene-based Advanced Therapy Medicinal Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Gene-based Advanced Therapy Medicinal Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Gene-based Advanced Therapy Medicinal Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Gene-based Advanced Therapy Medicinal Market Drivers
Figure 19. Gene-based Advanced Therapy Medicinal Market Restraints
Figure 20. Gene-based Advanced Therapy Medicinal Market Trends
Figure 21. Biogen Recent Developments and Future Plans
Figure 22. Novartis Recent Developments and Future Plans
Figure 23. Gilead Sciences Recent Developments and Future Plans
Figure 24. Sarepta Therapeutics Recent Developments and Future Plans
Figure 25. Alnylam Pharmaceuticals Recent Developments and Future Plans
Figure 26. Amgen Recent Developments and Future Plans
Figure 27. Spark Therapeutics Recent Developments and Future Plans
Figure 28. Akcea Therapeutics Recent Developments and Future Plans
Figure 29. Sunway Biotech Recent Developments and Future Plans
Figure 30. SIBIONO Recent Developments and Future Plans
Figure 31. AnGes Recent Developments and Future Plans
Figure 32. Orchard Therapeutics Recent Developments and Future Plans
Figure 33. Human Stem Cells Institute Recent Developments and Future Plans
Figure 34. Global Gene-based Advanced Therapy Medicinal Revenue Share by Players in 2021
Figure 35. Gene-based Advanced Therapy Medicinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 36. Global Top 3 Players Gene-based Advanced Therapy Medicinal Revenue Market Share in 2021
Figure 37. Global Top 10 Players Gene-based Advanced Therapy Medicinal Revenue Market Share in 2021
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 39. Global Gene-based Advanced Therapy Medicinal Revenue Share by Type in 2021
Figure 40. Global Gene-based Advanced Therapy Medicinal Market Share Forecast by Type (2023-2028)
Figure 41. Global Gene-based Advanced Therapy Medicinal Revenue Share by Application in 2021
Figure 42. Global Gene-based Advanced Therapy Medicinal Market Share Forecast by Application (2023-2028)
Figure 43. North America Gene-based Advanced Therapy Medicinal Sales Market Share by Type (2017-2028)
Figure 44. North America Gene-based Advanced Therapy Medicinal Sales Market Share by Application (2017-2028)
Figure 45. North America Gene-based Advanced Therapy Medicinal Revenue Market Share by Country (2017-2028)
Figure 46. United States Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Gene-based Advanced Therapy Medicinal Sales Market Share by Type (2017-2028)
Figure 50. Europe Gene-based Advanced Therapy Medicinal Sales Market Share by Application (2017-2028)
Figure 51. Europe Gene-based Advanced Therapy Medicinal Revenue Market Share by Country (2017-2028)
Figure 52. Germany Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Gene-based Advanced Therapy Medicinal Sales Market Share by Type (2017-2028)
Figure 58. Asia-Pacific Gene-based Advanced Therapy Medicinal Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Gene-based Advanced Therapy Medicinal Revenue Market Share by Region (2017-2028)
Figure 60. China Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South Korea Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Gene-based Advanced Therapy Medicinal Sales Market Share by Type (2017-2028)
Figure 67. South America Gene-based Advanced Therapy Medicinal Sales Market Share by Application (2017-2028)
Figure 68. South America Gene-based Advanced Therapy Medicinal Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East and Africa Gene-based Advanced Therapy Medicinal Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Gene-based Advanced Therapy Medicinal Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Gene-based Advanced Therapy Medicinal Revenue Market Share by Country (2017-2028)
Figure 74. Turkey Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. UAE Gene-based Advanced Therapy Medicinal Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
